We are live on
!
Find out more
GD
Grandfield & Dodd Portfolio holdings
AUM
$1.77B
1-Year Est. Return
23.43%
This Fund
S&P 500
This Quarter
Est. Return
-2.8%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.22B
AUM Growth
-$44.8M
(-3.5%)
Cap. Flow
+$3.01M
Cap. Flow
% of AUM
0.25%
Top 10 Holdings %
Top 10 Hldgs %
29.85%
Holding
194
New
3
Increased
55
Reduced
48
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$950K |
| 2 |
Chubb
CB
|
+$761K |
| 3 |
Blackbaud
BLKB
|
+$689K |
| 4 |
Hexcel
HXL
|
+$638K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$628K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brunswick
BC
|
+$1.84M |
| 2 |
FedEx
FDX
|
+$1.8M |
| 3 |
Microsoft
MSFT
|
+$1.69M |
| 4 |
Synopsys
SNPS
|
+$1.41M |
| 5 |
Apple
AAPL
|
+$727K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.18% |
| 2 | Healthcare | 16.06% |
| 3 | Industrials | 11.8% |
| 4 | Financials | 11.68% |
| 5 | Consumer Staples | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Salesforce
CRM
$154B
| $210K | 0.02% |
1,491
| – | – |
|
177
IDEX
IEX
$17B
| $210K | 0.02% |
+1,062
| New | +$215K |
|
178
Innospec
IOSP
$2.09B
| $210K | 0.02% |
2,400
| – | – |
|
179
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
| $210K | 0.02% |
2,091
| – | – |
|
180
Nucor
NUE
$58.3B
| $210K | 0.02% |
1,996
| – | – |
|
181
Wells Fargo
WFC
$254B
| $210K | 0.02% |
5,276
-1,340
| -20% | -$57.6K |
|
182
PNC Financial Services
PNC
$99.1B
| $200K | 0.02% |
1,368
-85
| -6% | -$13.8K |
|
183
Starbucks
SBUX
$119B
| $200K | 0.02% |
+2,410
| New | +$205K |
|
184
UnitedHealth
UNH
$382B
| $200K | 0.02% |
400
| – | – |
|
185
Nektar Therapeutics
NKTR
$2.39B
| $80K | 0.01% |
1,671
-583
| -26% | -$34.7K |
|
186
Blackrock
BLK
$167B
| – | – |
-338
| Closed | -$210K |
|
187
Enterprise Products Partners
EPD
$83.7B
| – | – |
-10,600
| Closed | -$260K |
|
188
Kraft Heinz
KHC
$32.8B
| – | – |
-6,165
| Closed | -$240K |
|
189
Northern Trust
NTRS
$21.8B
| – | – |
-2,147
| Closed | -$210K |
|
190
NVIDIA
NVDA
$4.6T
| – | – |
-16,270
| Closed | -$250K |
|
191
Vanguard FTSE Emerging Markets ETF
VWO
$117B
| – | – |
-5,410
| Closed | -$230K |
|
192
Vanguard High Dividend Yield ETF
VYM
$80.8B
| – | – |
-1,994
| Closed | -$200K |
|
193
Verizon
VZ
$197B
| – | – |
-8,359
| Closed | -$420K |
|
194
Dentsply Sirona
XRAY
$2.84B
| – | – |
-5,995
| Closed | -$210K |
|
Similar funds
HHAM
FFS
KOCAA
CGH
SW
BCMIO
UF
SLF
Grandfield & Dodd's Q3 2022 Portfolio in Review
As of Q3 2022, Grandfield & Dodd held 194 positions worth $1.22B, down 3.5% from $1.27B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Grandfield & Dodd's Q3 2022 filing shows 3 new, 55 increased, 48 reduced and 9 closed positions. Its largest new stake was Genmab: 10,210 shares worth $330K. The largest sale was Brunswick, an estimated $1.84M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
- Grandfield & Dodd's largest Q3 2022 buy was Genmab: 10,210 shares worth $330K.
- Grandfield & Dodd added most to People Inc in Q3 2022, an estimated $950K increase.
- Grandfield & Dodd's biggest Q3 2022 reduction was Brunswick, cutting an estimated $1.84M.
- Grandfield & Dodd fully exited Verizon in Q3 2022, selling an estimated $420K.
- Grandfield & Dodd's ten largest holdings make up 30% of its $1.22B portfolio in Q3 2022.
- Grandfield & Dodd opened 3 new positions and closed 9 in Q3 2022.
- Grandfield & Dodd's portfolio value fell 3.5% quarter-over-quarter to $1.22B.
Based on Grandfield & Dodd's 13F filing for Q3 2022, filed 4 Nov 2022.